Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in a deal worth EUR 1.5 billion. This move comes after more than 25 years of successful collaboration, driven by a strategic repositioning at dsm-firmenich. Novonesis CEO Ester Baiget expressed excitement over the acquisition,…